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ABSTRACT: 
GATA2 mutations have been identified in various diseases, such as monoMAC syndrome, 
Emberger syndrome, familial myelodysplastic syndrome, acute myeloid leukemia, and 
dendritic cell, monocyte, B and NK cell deficiency. These syndromes present a wide range of 
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clinical features, dominated by severe infections and haematological disorders such as 
myelodysplastic syndrome. Up to 70% of GATA2-mutated patients have dermatological 
features, mainly genital or extra-genital warts, panniculitis or erythema nodosum, and 
lymphedema. We report 3 patients presenting with common dermatological and 
haematological features leading to the diagnosis of GATA2 deficiency, but also with skin 
manifestations that have not been previously described: gingival hypertrophy, macroglossitis 
and glossitis, and granulomatous lupoid facial lesions. Dermatologists can encounter 
GATA2-mutated patients and should recognize this disorder. 
 
INTRODUCTION: 
 
Heterozygous mutations of GATA2, a zinc finger transcription factor, were first 
described in 2011 by Hsu et al.
1 
in patients with monocytopenia and mycobacterial infections
(monoMAC). Further research has confirmed GATA2 mutations in dendritic cell, monocyte, 
B- and natural killer (NK-) cell deficiency
2
, in familial myelodysplastic syndrome/acute
myeloid leukemia (MDS/AML)
3
 and in Emberger syndrome (primary lymphedema with
myelodysplasia). Spinner et al.
4 
reviewed the medical records of 57 patients with GATA2
mutations and identified a broad spectrum of clinical characteristics with predominantly 
hematological, infectious, pulmonary, dermatological, neoplastic, vascular and lymphatic 
features. 
 We report on three GATA2-mutated patients where cutaneous features preceded the 
manifestations related to other organ systems. 
 
 
A
cc
ep
te
d 
A
rt
ic
le
. 
CASE REPORTS: 
Case 1: 
 A twelve-year-old white patient was referred to our department for lymphedema of the 
right lower leg, evolving since the age of eleven. 
He had no medical history until he was 9 when he started to have recurrent aphta and 
epistaxis. At 11, he developed lymphedema of the right leg. 
Physical examination evidenced bilateral lymphedema, plantar warts and gingival 
hypertrophy which was often hemorrhagic (Figures 1 A and B). The patient was hospitalized 
for cellulitis of the right leg, treated with antibiotics. 
Blood cell counts revealed a normal haemoglobin level alongside macrocytosis, normal 
platelet count, but low levels of neutrophils, lymphocytes and monocytes. A bone marrow 
biopsy showed dysmyelopoiesis, without myelodysplastic syndrome, and medium 
megakaryocyte density without excess blasts. The bone marrow karyotype was normal. The 
association of congenital lymphedema, multiple warts and leucopenia pointed to Emberger 
syndrome. Genetic testing confirmed GATA2 mutation (c.1084C>T (p.R362X) on exon 5). 
Further tests are underway to investigate any deafness and to study familial GATA2 mutation 
status. 
 
Case 2 
A 28-year-old woman was admitted to the Respiratory department with increasing 
shortness of breath, dry cough and interstitial lung disease. Surgical pulmonary biopsy 
showed pulmonary alveolar proteinosis, and broncho-alveolar lavage evidenced lymphocytic 
alveolitis. 
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She had a history of idiopathic lymphedema affecting both lower legs, diagnosed five years 
earlier (Figure 1C). Lymphoscintigraphy suggested lymphatic vessel hypoplasia. 
Physical examination also revealed multiple warts on the hands, sclerodermiform lesions on 
the legs and panniculitis on the upper limbs (Figure 1C). 
Biopsies of the upper limb lesions concluded to erythema nodosum. The two biopsies showed 
roughly similar lesions. They were both performed in the subcutis, totally sparing the 
overlying epidermis and dermis. They showed thick sclerosis with horizontal, thickened and 
hyalinized collagen bundles associated with fragmented elastic fibers (Orcein). In the 
periphery some inflammatory cells were observed, grouped in clusters (Figure 1 D and E). 
Long-term cultures for mycobacteria were negative in the skin biopsies. 
She had an enlarged tongue with several depapillated areas, and she complained of 
dysgueusia (Figure 1 F). 
Blood cell counts showed pancytopenia. Bone marrow biopsy was normo-cellular with three-
lineage dysplasia. Myelodysplastic syndrome (MDS) without karyotype anomaly was 
diagnosed. She was thought to have MonoMAC syndrome, and GATA2 mutation 
(c.1020_1029dup (p.R3444GfsX43) on exon 5) was identified. Over 9 months, MDS 
remained stable but her respiratory parameters deteriorated. Hematopoietic stem-cell 
transplantation (HSCT) is being considered. 
 
Case 3 
A 20-year-old white woman was referred to the hematology department for 
pancytopenia lasting 5 years. In childhood she experienced recurrent ear, nose and throat 
(ENT) infections (otitis, rhinitis) and labial herpes. 
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She presented with fatigue, weight loss, multiple warts on both hands, and lupoid lesions of 
the cheeks, forehead and temples (Figure 2 A and B). These facial lesions first appeared at 
age fifteen and none of the different treatments (topics, metronidazole, cyclins and zinc) was 
effective. 
Two skin biopsies were performed at 2 different times, showing a granulomatous infiltrate in 
the upper and mid dermis in the two lesions, located mainly between hair follicles. This 
infiltrate was mostly made up of histiocytes, some of them epithelioid, associated with giant 
multinucleated cells and neutrophils in the deeper part.  (Figure 2 C). 
Bacterial, mycobacterial and fungal staining tests were negative. Cutaneous cultures were 
negative for bacteria, mycobacteria and fungi. 
Blood cell counts revealed pancytopenia (including low hemoglobin, low platelet, white 
blood cell, neutrophil, lymphocyte and monocyte counts). Bone marrow examination showed 
three-lineage dysplasia leading to the diagnosis MDS. Her karyotype was normal. A GATA2 
mutation (c.1060A>C (p.T354P) on exon 5) was identified and she was diagnosed with 
MonoMAC syndrome. 
Her parents and sister were tested, but no GATA2 mutation was detected, suggesting that the 
patient's disorder was caused by de-novo mutation. 
Because of the risk of acute myeloid leukemia (AML), she underwent curative pheno-
identical allogenic stem-cell transplantation after chemotherapy. 
Five months after transplantation she had no further ENT infection and the facial cutaneous 
lesions rapidly healed. Blood cell counts were within the normal range and the bone marrow 
showed total remission. Lymphedema of both lower limbs occurred a few month after 
hematopoietic stem cell transplantation. 
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Table 1 summarizes clinical and blood test results for the 3 patients. 
 
DISCUSSION: 
GATA2 is a zinc finger transcription factor that regulates early haematopoietic 
differentiation, and lymphatic and vascular development. Nearly 100 GATA2 mutations have 
been described. They appear to cause loss of function of the mutated allele
1,4,5
. Germline
mutations arise spontaneously (de novo) but are then transmitted via autosomal dominant 
inheritance. 
GATA2 mutations have been identified in more than 300 patients and 3 large cohorts 
of GATA2-mutated patients have been reported
4–6
.
 
Median age at the first clinical manifestations is 20 years (range 5 months to 78 
years), although some individuals seem to have no clinical manifestation. Survival has been 
estimated at 91% 5 years after onset of symptoms and 67% 20 years after onset
4–6
.
GATA2-mutated patients have very heterogeneous presentations (Figure 3) and a wide 
range of severity, from asymptomatic to life-threatening infections, respiratory failure and 
leukemia. 
Dermatological features appear to be secondary to several conditions. Up to 70% of 
patients have persistent HPV infections
6
. Severe HPV infections are recalcitrant, possibly
generalized, warts and condylomata
4–6
. Absence of cellular immunity caused by the paucity
of NK-cells or their dysfunction leads to these severe manifestations. Our 3 patients had 
numerous warts on the limbs. Patient 2 had no recurrence of warts after HSCT. Patients 1 and 
3 had limited manifestations, but were resistant to the treatments instated. Patients infected 
with oncogenic
7
 and non-oncogenic
8
 HPVs have been reported. The majority of these
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patients develop warts years before GATA2 diagnosis. They may develop HPV-related skin 
malignancies, including squamous intra-epithelial lesions, bowenoid papulosis and invasive 
squamous cell carcinoma. Early HPV vaccination is recommended after GATA2 mutation 
diagnosis. 
Other severe infections induced by immunodeficiency in GATA2 syndromes may also 
entail cutaneous manifestations. Non-tuberculous mycobacterial infections have been 
described with dermatological manifestations such as ulcers of the lower limbs
9
 and nodular
skin lesions
4
. The most frequent complication is cellulitis. Lymphedema, with early care, can
be managed with compression stockings, as for patient 1 in our report. For patients 1 and 2 
lymphedema was the first symptom of their disease. 
Up to one third of GATA2-mutated patients have erythema nodosum or panniculitis, 
usually on the lower extremities. These conditions can have several causes: NTM infections, 
bacterial infections or auto-immune phenomena
10
 (lupus-like syndromes, primary biliary
cirrhosis-like liver damage and multiple sclerosis-like syndrome). Here, one of the patients 
(Case 2) presented with sclerodermiform changes located deep in the subcutis, resembling 
deep morphea. Skin biopsies show panniculitis, erythema nodosum or granulomatous lesions. 
Bacteriological samples of nodular lesions may evidence non-tuberculous mycobacteria such 
as M szulgai, M avium complex, M abcessus. 
Finally, dermatological manifestations can be neoplastic. Chronic, recurrent warts and 
condylomata may evolve into squamous intra-epithelial dysplasia or squamous cell 
carcinoma. Monitoring of patients by dermatologists is therefore important. Non HPV-related 
squamous-cell and basal-cell carcinomas have also been described
10,11
. Additionally
melanoma and 3 cases of Sweet syndrome are reported in the setting of underlying 
MDS/AML
4
.
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Our patients had unusual cutaneous manifestations not described previously. Patient 1 
had a history of gingival hypertrophy and recurrent aphta. Patient 3 had a distinctive 
presentation involving lupoid lesions located exclusively on her face. The skin biopsy 
revealed granulomatous lesions with mixed acute and chronically inflammatory cells. 
Granulomatous skin lesions can occur in patients with immunodeficiency from diverse 
causes
12
. In our patient, the negative microbiological investigations and the resolution after
HSCT are suggestive of this mechanism. Manifestations associated with GATA-2 dysfunction 
are numerous, they are expressed in a large array of organs, and can be related to several 
causes (neoplastic, infectious, immunodeficiency).  In our patients, it is difficult to ascertain 
the novelty of the manifestations. If gingival hypertrophy is rather non-specific, the particular 
presentation of facial non-infectious granulomatous dermatosis (case 3) is worth mentioning, 
since it has not been reported as a manifestation in other immunodeficiencies. The 
sclerodermiform changes (case 2) constitute a new finding, although we are unable to provide 
any clue to the related mechanisms. 
In conclusion, we highlight both well-known and new dermatological features in the 
recently-described GATA2 mutation clinical spectrum. As they can precede other clinical 
symptoms, dermatologists are crucial in early diagnosis of this multiform disease. 
Dermatological monitoring is important for patients identified in order to detect or prevent 
HPV-related or non-HPV-related skin cancers. 
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Patient 
Present 
age 
Gender 
Dermatologic clinical features 
(age at onset: years) 
Haematologic signs 
Age at first 
haematological 
sign 
Other clinical features (age 
at onset: years) 
Age at 
first 
visit 
Age at 
diagnosis 
GATA2 mutation 
Protein 
Treatment 
(age: years) 
Case 1 
 
 
 
12 years 
M 
Recurrent aphta (9) 
Warts  
Lymphedema of lower right leg (11) 
Cellulitis of right lower leg (12) 
Gingival hypertrophy (9) 
Macrocytosis 
Neutropenia 
Monocytopenia 
Low level of gammaglobulin 
(IgG) 
Myelodyspoiesis without MDS 
Normal karyotype 
11 years Epistaxis (9) 
11 
years 
12 years 
c.1084C>T
p.R362X
exon 5 
None 
Case 2 
 
 
 
31 years 
F 
Bilateral lymphedema (right>left) 
(23) 
Deep morphea-like lesions (28) 
Glossitis (28) 
Telogen effluvium (29) 
Warts  
Anemia 
Thrombopenia 
Monocytopenia 
MDS 
Hypergammaglobulinemia 
Normal karyotype 
28 years 
Pulmonary alveolar 
proteinosis (28) 
Fatigue, loss of weight (28) 
Phyllodes tumor of left breast 
(30) 
menometrorrhagia (29) 
Pulmonary pneumocystis and 
aspergillosis colonisation (30) 
23 
years 
28 years 
c.1020_1029dup
p.R3444GfsX43 
exon 5 
Allogenic HSCT 
and pulmonary 
graft under 
consideration 
Case 3 
 
 
 
20 years 
F 
Recurrent labial herpes (childhood) 
Warts  
Lupoid lesions of the face (10): 
granulomatous aseptic lesions 
Bilateral lymphedema of lower legs 
Anemia 
Thrombopenia 
Monocytopenia 
B-cell lymphopenia 
MDS 
Low level of IgA 
Normal karyotype 
11 years 
Fatigue, loss of weight (11) 
Recurrent ENT infections 
(childhood) 
Influenza 
11 
years 
19 years 
c.1060A>C
p.T354P 
exon 5 
Allogenic HSCT 
(19) 
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